Urja Global Limited (BOM:526987)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	34.86	12.39	5.78	0.48	3.86
Short-Term Investments	-	-	-	54.89	0.53
Cash & Short-Term Investments	34.86	12.39	5.78	55.38	4.39
Cash Growth	181.40%	114.35%	-89.56%	1162.19%	-0.88%
Accounts Receivable	227.71	150.71	102.86	590.18	436.93
Other Receivables	-	-	-	-	0.48
Receivables	227.71	187.56	102.86	766.32	620.54
Inventory	405.74	391.82	200.2	137.66	79.11
Prepaid Expenses	-	0.81	0.18	0.12	0.11
Other Current Assets	154.89	55.05	61.74	21.1	14.57
Total Current Assets	823.2	647.62	370.76	980.57	718.71
Property, Plant & Equipment	835.83	891.94	948.93	940.22	942.04
Long-Term Investments	7.04	7.04	6.53	6.53	6.53
Goodwill	437.37	438.7	438.7	438.7	438.7
Long-Term Accounts Receivable	647.94	681.96	907.36	3,275	3,181
Long-Term Deferred Tax Assets	0.09	0.14	0.29	0.32	0.35
Long-Term Deferred Charges	-	2.58	4.49	5.74	4.98
Other Long-Term Assets	158.54	0	0.51	0.51	0.93
Total Assets	2,910	2,826	2,853	5,648	5,294
Accounts Payable	67.65	72.07	85.33	350.31	791.48
Accrued Expenses	-	3.59	13.7	33.18	43.47
Short-Term Debt	465.93	339.88	204.2	24.21	13.25
Current Portion of Long-Term Debt	-	-	-	-	5.8
Current Income Taxes Payable	-	36.92	37.91	36.79	41.32
Other Current Liabilities	40.68	4.27	7.84	67.75	12.65
Total Current Liabilities	574.27	456.73	348.98	512.24	907.98
Long-Term Debt	53.91	30.27	34.62	34.62	29.98
Other Long-Term Liabilities	385.79	455.44	656.09	3,303	2,597
Total Liabilities	1,014	942.44	1,040	3,850	3,535
Common Stock	533.9	533.9	533.9	533.9	557.21
Additional Paid-In Capital	-	406.69	406.69	743.49	686.71
Retained Earnings	-	433.34	412.98	60.94	55.32
Comprehensive Income & Other	1,219	365.85	365.85	365.85	365.85
Total Common Equity	1,752	1,740	1,719	1,704	1,665
Minority Interest	143.55	143.77	93.78	93.75	93.75
Shareholders' Equity	1,896	1,884	1,813	1,798	1,759
Total Liabilities & Equity	2,910	2,826	2,853	5,648	5,294
Total Debt	519.84	370.15	238.83	58.83	49.03
Net Cash (Debt)	-484.98	-357.76	-233.05	-3.46	-44.65
Net Cash Per Share	-0.92	-0.67	-0.44	-0.01	-0.09
Filing Date Shares Outstanding	592.5	533.39	533.39	537.93	519.71
Total Common Shares Outstanding	592.5	533.39	533.39	537.93	519.71
Working Capital	248.93	190.89	21.78	468.33	-189.27
Book Value Per Share	2.96	3.26	3.22	3.17	3.20
Tangible Book Value	1,315	1,301	1,281	1,265	1,226
Tangible Book Value Per Share	2.22	2.44	2.40	2.35	2.36
Land	-	20.7	20.7	20.7	20.7
Buildings	-	34.04	34.04	21.24	20.71
Machinery	-	58.78	56.28	27.63	26.93
Construction In Progress	-	852.57	909.11	897.97	897.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.